Clinical implications of discordance in HER2 reassessment from HercepTest to 4B5 in metastatic breast cancer. - Yamaguchi Y; Hoshino M; Shimoi T; Tamura H; Natori Y; Saiki T; Yamanaka T; Kitadai R; Saito A; Kita S; Maejima A; Kojima Y; et al. (Breast cancer research and treatment, 2026)